Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Testosterone is key for male sexual function, and treating hormone imbalances can improve sexual issues.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Long-term Finasteride treatment reduces depression better than short-term treatment in rats.

Finasteride 5mg daily is the most effective for female pattern hair loss, with higher doses of treatments generally more effective.

A man's low testosterone and related symptoms improved after he stopped taking hair loss drugs.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Drugs for prostate enlargement and hair loss were not linked to increased risk of depression or suicide.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

5-α reductase inhibitors do not significantly affect male reproductive function but may reduce semen volume.

The document suggests that drugs for prostate issues might cause lasting sexual, mental, and physical health problems due to blood vessel damage in the penis.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Finasteride does not negatively affect male reproductive function.

Dutasteride use can lead to a stable decline in sexual function that is not affected by age or prostate size.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

5-alpha-reductase inhibitors significantly affect the penile tissue of hypertensive rats.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

5α-Reductase inhibitors may increase depression risk but not dementia or suicide.